Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Macrophages expressing Neuropilin-1 (NRP-1) contribute to antitumor immune responses.
• The specific role of NRP-1 on macrophages in antibody-mediated tumoricidal activity requires further elucidation.

Purpose of the Study:

• To investigate the function of NRP-1 expressed on macrophages in antibody-dependent cellular cytotoxicity (ADCC).
• To assess the impact of NRP-1 modulation on macrophage-mediated antitumor immunity in vitro and in vivo.

Main Methods:

• Macrophage treatment with NRP-1 knockdown or anti-NRP-1-neutralizing antibodies in vitro.
• In vivo studies using a humanized mouse model with HER2-positive breast cancer xenografts.
• Co-administration of anti-HER2 antibody with NRP-1 knockdown peripheral blood mononuclear cells.

Main Results:

• NRP-1 knockdown or blockade significantly suppressed antibody-dependent cellular cytotoxicity and altered cytokine secretion from macrophages.
• In vivo, antibody-mediated antitumor activity and CD4+ T lymphocyte infiltration were downregulated when NRP-1 was knocked down on co-administered cells.
• These findings highlight NRP-1's critical role in macrophage-mediated antitumor immunity.

Conclusions:

• Neuropilin-1 on macrophages is essential for effective antibody-mediated antitumor immunity.
• NRP-1 expression on macrophages may serve as a predictive biomarker for antibody-based cancer therapies.
• Further research is warranted to validate NRP-1 as a therapeutic indicator for ADCC-mediating antibody treatments.